Fulgent Genetics provides genetic and diagnostic lab testing for healthcare providers and patients, and develops cancer drug candidates. FLGT reports earnings on Thu, Nov 5, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 4 | Piper Sandler | Maintained | Hold |
Seasonality
How FLGT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.
Whale Options Flow
90DNo whale options trades in FLGT in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FLGT is in one of them and how their past FLGT trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered FLGT in an article yet. Here's the latest on the wider market.
About Fulgent Genetics
Fulgent Genetics is a laboratory services company based in El Monte, California. It offers genetic testing, diagnostic testing, anatomic pathology services, and physician interpretation of lab results. Its customers include insurers, hospitals, medical institutions, pharmaceutical and biotech companies, and patients who pay directly for tests. The company is also developing cancer drug candidates that use a nanoencapsulation platform.
- Headquarters
- El Monte, CA
- Founded
- 2011
- Website
- fulgentgenetics.com ↗